Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Advances in Fractional and Nonfractional Laser Treatments

Description

The discussion on laser treatments covers significant advancements in both fractional and non-fractional laser technologies. The focus is particularly on the development of a non-ablative laser treatment with a novel focal point technology that penetrates deeper into the dermis while minimizing pain and downtime. This technology allows practitioners to adjust energy levels, achieving effective outcomes for various skin concerns, including volumization, skin tightening, and treatment for conditions like acne scarring. Clinical results indicate increased patient acceptance and a broadening range of uses, especially for patients with darker skin types. The presenter notes how they have significantly increased the use of this technology in practice and highlights its effectiveness when combined with other treatments, such as for vascular lesions and drug delivery systems. Additionally, the efficacy of laser-assisted drug delivery is emphasized, showcasing the enhanced absorption of topical treatments post-laser therapy, revealing its potential to improve overall therapeutic outcomes. As practice evolves, the integration of these advanced laser technologies is expected to enhance treatment results while ensuring safety and patient satisfaction.

View more

Conclusions

  • The new Focal Point Technology significantly enhances non-ablative laser treatment's depth and energy delivery while minimizing skin damage.
  • Patients report reduced pain and minimal downtime with this advanced laser technology.
  • The treatment shows promising results for skin tightening and volumization, especially in areas like the cheeks and around the mouth.
  • Clinical applications of the technology are expanding, with increased patient acceptance and varied uses identified in practices.
  • Long-term outcomes indicate the need for maintenance treatments as results may not be permanent beyond six months.
  • Focal Point Technology is effective for treating acne scarring and vascular lesions, with improved results over traditional methods.
  • Laser-assisted drug delivery demonstrates considerable potential in enhancing therapeutic outcomes across several dermatological conditions.
  • Wang JV, Mehrabi JN, Zachary CB, Geronemus RG. Evaluation of Device-Based Cutaneous Channels Using Optical Coherence Tomography: Impact for Topical Drug Delivery. Dermatol Surg. 2022 Jan 1;48(1):120-125.
  • Ali Rkein, MD, David Ozog, MD, Jill S. Waibel, MD. Treatment of Atrophic Scars with Fractionated CO2 Laser Acid. Dermatol Surg 2014;40:624-631.
  • Ibrahim O, Ionta S, Depina J, Petrell K, Arndt KA, Dover JS. Safety of Laser-Assisted Delivery of Topical Poly-L-Lactic Acid in the Treatment of Upper Lip Rhytides: A Prospective, Rater-Blinded Study. Dermatol Surg 2019; 00:1-7.
  • Jordan V Wang, Nkemjika Ugonabo, Roy G Geronemus. Fractional Ablative Laser-Assisted Delivery of Topical Poly-L-Lactic Acid: A 2.5-Year Safety Review. Dermatol Surg 2022 Feb 1;48(2):258-259.
  • Wang JV, Friedman PM, Agron S, Konda A, Parker C, Geronemus RG. Mineral Eye Serum Permeation - Low-Power 1927nm and 1440nm. Derm Surg 2022;48(8):822-826.